Excessive release of CGRP is associated with the development of migraine headache,osteoarthritis pain, complex regional pain syndrome, and diabetic neuropathy [38, 39]; whereas ADM signaling is associated withtumor growth/metastasis. This evidence concerns the gene CALCA and Headache.